Skip to Content

Join the 'Urinary Tract Tumors' group to help and get support from people like you.

Urinary Tract Tumors News

Do Overweight People Fare Better Than Others With Kidney Cancer?

Posted 7 Sep 2016 by Drugs.com

WEDNESDAY, Sept. 7, 2016 – Obesity is a risk factor for kidney cancer. Yet, obese people with advanced kidney cancer seem to live longer than normal-weight or underweight patients, a new study finds. In one database of nearly 2,000 patients with advanced kidney cancer, those who were obese or overweight survived nearly 26 months, compared to 17 months for those of normal weight. And, overweight patients were 16 percent less likely to die during the study period, the researchers reported. Similar findings were uncovered using three other databases. The records of more than 7,000 kidney cancer patients were reviewed by the study authors. "Paradoxically, when overweight individuals developed kidney cancer, especially in its advanced, metastatic form, their disease progressed more slowly and they lived longer than their normal-weight counterparts," said lead researcher Dr. Toni Choueiri. ... Read more

Related support groups: Obesity, Cancer, Renal Failure, Renal Cell Carcinoma, Chronic Kidney Disease, Urinary Tract Tumors, Wilms' Tumor, Urinary Tract Cancer

15.5 Million Americans Now Surviving Cancer: Report

Posted 2 Jun 2016 by Drugs.com

THURSDAY, June 2, 2016 – Cancer survivors in the United States reached record numbers this year – 15.5 million – and the American Cancer Society predicts they'll total more than 20 million in another decade. But along with these success stories comes a growing demand for medical, emotional and psychological support to aid survivors' long-term recovery, according to a new cancer society report. "Many cancer survivors have to cope with long-term physical and psychological effects of their cancer treatment," said lead researcher Kimberly Miller, an American Cancer Society epidemiologist. "It's important for the public health community to have a better understanding of the current and future needs of these survivors." Although new cancer cases are on the decline in the United States, survival numbers are up because of improved detection and treatment, as well as a growing and aging ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Melanoma, Breast Cancer, Prevention, Urinary Tract Tumors, Urinary Tract Cancer

Targeted Drug Shows Promise Against Advanced Kidney Cancer

Posted 6 Jan 2016 by Drugs.com

WEDNESDAY, Jan. 6, 2016 – A targeted cancer drug appears to be effective against advanced kidney cancer, although its side effects may keep it from becoming widely used, researchers report. The drug, cabozantinib, proved more effective across-the-board in kidney cancer patients than another targeted drug called everolimus, said lead researcher Dr. Bernard Escudier. He is chair of the genitourinary oncology committee at the Institut Gustave Roussy in Villejuif, France. Overall, cabozantinib provided "almost a 50 percent improvement in progression-free survival" over everolimus, Escudier said. Cabozantinib works by interrupting several different cellular processes that help cancer grow and spread, Escudier explained. Unfortunately, that widespread approach also creates worrisome toxic side effects, he added. "Based on this multi-targeted action, we have quite a lot of side effects. ... Read more

Related support groups: Cancer, Renal Failure, Renal Cell Carcinoma, Chronic Kidney Disease, Solid Tumors, Cometriq, Urinary Tract Tumors, Urinary Tract Cancer, Cabozantinib

U.S. Oncologists Decry High Cost of Cancer Drugs

Posted 23 Jul 2015 by Drugs.com

THURSDAY, July 23, 2015 – Soaring costs for cancer drugs are hurting patient care in the United States, a group of top oncologists claim. "High cancer-drug prices are affecting the care of patients with cancer and our health care system," Dr. Ayalew Tefferi, a hematologist at Mayo Clinic in Rochester, Minn., said in a Mayo news release. Tefferi and his colleagues made a number of recommendations on how to address the problem in a commentary published July 23 in the Mayo Clinic Proceedings. Allowing Medicare to negotiate drug prices is one of the suggestions the team of 118 leading cancer experts offered as a possible solution. Along with their recommendations, the group also expressed support for a patient-based grassroots movement on change.org that is demanding action on the issue. "The average gross household income in the U.S. is about $52,000 per year. For an insured patient with ... Read more

Related support groups: Cancer, Provera, Depo-Provera, Methotrexate, Breast Cancer, Accutane, Lupron, Prostate Cancer, Tamoxifen, Medroxyprogesterone, Arimidex, Tretinoin, Fluorouracil, Femara, Lupron Depot, Gleevec, Lung Cancer, Renal Cell Carcinoma, Colorectal Cancer, Isotretinoin

Ingredient in Botanicals Tied to Urinary Cancer

Posted 23 Dec 2009 by Drugs.com

TUESDAY, Dec. 22 – New research links a carcinogen known as aristolochic acid, which is found in some Chinese herbal products, including guan mu-tong, to a higher risk of urinary tract cancer. The findings were reported online Dec. 21 in the Journal of the National Cancer Institute. The study involved 4,594 people in Taiwan who had just been diagnosed with urinary tract cancer, as well as a random sample of 174,701 people from the country. The cancer rate was higher among those who had been prescribed more than 60 grams of mu-tong (which the researchers said might have had guan mu-tong in it) and among people who had consumed an estimated 150 milligrams or more of aristolochic acid. "In addition to a ban on products that contain any amount of aristolochic acid, we also recommend continued surveillance of herbs or Chinese herbal products that might be adulterated with ... Read more

Related support groups: Urinary Tract Tumors

Ask a Question

Further Information

Related Condition Support Groups

Cancer

Related Drug Support Groups

bcg, Tice BCG, Valstar, TheraCys, valrubicin